The Effect of Renal Impairment on the Pharmacokinetics and Safety of Itacitinib
暂无分享,去创建一个
Gongfu Zhou | T. Marbury | Xuejun Chen | S. Yeleswaram | N. Punwani | Susan L Petusky | N. Srinivas | A. Barbour | Noam U. Epstein | B. Yuska | Zhinyin Xun | Naresh Punwani
[1] Xuejun Chen,et al. Effect of Itraconazole or Rifampin on Itacitinib Pharmacokinetics When Administered Orally in Healthy Subjects , 2019, Journal of clinical pharmacology.
[2] A. Im,et al. Trial in Progress: A Phase 3 Study of Itacitinib or Placebo in Combination with Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease (GRAVITAS-309) , 2019, Blood.
[3] D. Mager,et al. Population Pharmacokinetics of Tacrolimus in Transplant Recipients: What Did We Learn About Sources of Interindividual Variabilities? , 2018, Journal of clinical pharmacology.
[4] J. Dipersio,et al. The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[5] M. Mohty,et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[6] H. Greinix,et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease , 2015 .
[7] D. Couriel,et al. Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: To Whom, When, and How , 2013, Current Oncology Reports.
[8] E. Cohen,et al. Chronic kidney disease after hematopoietic stem cell transplantation. , 2010, Seminars in nephrology.
[9] AW Dreisbach. The Influence of Chronic Renal Failure on Drug Metabolism and Transport , 2009, Clinical pharmacology and therapeutics.
[10] S. Akman,et al. Renal function after hematopoietic stem cell transplantation in children , 2009, Pediatric blood & cancer.
[11] T. Nolin,et al. Emerging Evidence of the Impact of Kidney Disease on Drug Metabolism and Transport , 2008, Clinical pharmacology and therapeutics.
[12] T. Nolin,et al. Hemodialysis acutely improves hepatic CYP3A4 metabolic activity. , 2006, Journal of the American Society of Nephrology : JASN.
[13] Daniel Wolff,et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[14] A. Dreisbach,et al. The Effect of Chronic Renal Failure on Hepatic Drug Metabolism and Drug Disposition , 2003, Seminars in dialysis.
[15] G. Park,et al. Effect of renal failure on drug metabolism by the liver. , 1993, British journal of anaesthesia.
[16] Stephanie J. Lee,et al. Recognizing and managing chronic graft-versus-host disease. , 2008, Hematology. American Society of Hematology. Education Program.
[17] Hong Sun,et al. Effects of renal failure on drug transport and metabolism. , 2006, Pharmacology & therapeutics.